Trial Details
COMPLETEDBasic Information
| Clinical ID | c4294 |
|---|---|
| Identifier | NCT00737789 |
| Trial Title | Mesalazine 4g Once Daily Versus 4g in Two Divided Doses in Active Ulcerative Colitis. |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: Mesalazine slow-release granules|DRUG: Mesalazine liquid enema |
Participant Information
| Sponsor | Ferring Pharmaceuticals |
|---|---|
| City | Aalst |
| Country/Region | Belgium |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2008-11 |
|---|---|
| Primary Completion Date | 2010-06 |
| Completion Date | 2010-06 |